Nanocrystals

Nanocrystals
Product Description

Development of drug to nanocrystals for higher bioavailability or long acting

Acon Pharmaceuticals

  • Country/Region:
    United States
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
CMO/CDMO
Consultancy
Contract Research Organisation (CRO)
Contract Service
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Pharmaceutical company
Start-up
Primary activities
Analytical Services
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Finished Formulation products Distributor/Buyer
Laboratory Services
Laboratory, Analytical, Biotechnology Equipment
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Technology

Acon Pharmaceuticals

  • Country/Region:
    United States
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
CMO/CDMO
Consultancy
Contract Research Organisation (CRO)
Contract Service
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Pharmaceutical company
Start-up
Primary activities
Analytical Services
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Finished Formulation products Distributor/Buyer
Laboratory Services
Laboratory, Analytical, Biotechnology Equipment
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Technology

More Products from Acon Pharmaceuticals (4)

Acon Pharmaceuticals resources (1)

  • News siRNA and mRNA LNP

    ACON Pharma provides development of mRNA, siRNA lipid nanoparticle (LNP) products as therapeutics or vaccine.